Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection

Journal of Clinical Investigation

Volumn 113, Issue 5, 2004, Pages 694-700

  Subudhi, Sumit K ^a   Zhou, Ping ^a   Yerian, Lisa M ^a   Chin, Robert K ^a   Lo, James C ^a   Anders, Robert A ^a   Sun, Yonglian ^a   Chen, Lieping ^b   Wang, Yang ^a   Alegre, Maria Luisa ^a   Fu, Yang Xin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; B7 H1 ANTIGEN; CD8 ANTIGEN; LIGAND; UNCLASSIFIED DRUG; 5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD3 ANTIGEN; COMPLEMENTARY DNA; CYTOKINE; FLUORESCEIN DERIVATIVE; FLUORESCENT DYE; HYBRID PROTEIN; MEMBRANE PROTEIN; PDCD1LG1 PROTEIN, MOUSE; PEPTIDE; PLASMA PROTEIN; SUCCINIMIDE DERIVATIVE;

ALLOGRAFT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL PROLIFERATION; CONTROLLED STUDY; DIABETES MELLITUS; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CD8+ T LYMPHOCYTE; CELL DIVISION; FLUORESCENCE MICROSCOPY; GLUCOSE BLOOD LEVEL; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; PANCREAS ISLET; PANCREAS ISLET TRANSPLANTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; TRANSGENIC MOUSE;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD3; ANTIGENS, CD80; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BLOOD GLUCOSE; BLOOD PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CYTOKINES; DIABETES MELLITUS, TYPE 1; DNA, COMPLEMENTARY; FLUORESCEINS; FLUORESCENT DYES; GRAFT REJECTION; IMMUNE TOLERANCE; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; PEPTIDES; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUCCINIMIDES; T-LYMPHOCYTES; TIME FACTORS;

EID: 85047690551     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI19210     Document Type: Article

References (40)

1. Dong, H., Zhu, G., Tamada, K., and Chen, L. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369.
2. Dong, H., et al. 2002. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8:793-800.
3. Tamura, H., et al. 2001. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood. 97:1809-1816.
4. Moore, K.W., de Waal Malefyt, R., Coffman, R.L., and O'Garra, A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
5. Freeman, G.J., et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192:1027-1034.
6. + T cells and is overcome by IL-2. Eur. J. Immunol. 32:634-643.
7. Ozkaynak, E., et al. 2002. Programmed death-1 targeting can promote allograft survival. J. Immunol. 169:6546-6553.
8. Bennett, F., et al. 2003. Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J. Immunol. 170:711-718.
9. Gao, W., Demirci, G., and Li, X.C. 2003. Negative T cell costimulation and islet tolerance. Diabetes Metab. Res. Rev. 19:179-185.
10. Mazanet, M.M., and Hughes, C.C. 2002. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J. Immunol. 169:3581-3588.
11. Rodig, N., et al. 2003. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur. J. Immunol. 33:3117-3126.
12. Selenko-Gebauer, N., et al. 2003. B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J. Immunol. 170:3637-3644.
13. Brown, J.A., et al. 2003. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J. Immunol. 170:1257-1266.
14. Curiel, T.J., et al. 2003. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat. Med. 9:562-567.
15. Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., and Honjo, T. 2003. PD-1 inhibits antiviral immunity at the effector phase in the liver. J. Exp. Med. 199:39-50.
16. Wintterle, S., et al. 2003. Expression of the B7-related molecule B7-H1 by glioma cells: a potential mechanism of immune paralysis. Cancer Res. 63:7462-7467.
17. Gao, W., Demirci, G., Strom, T.B., and Li, X.C. 2003. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival. Transplantation. 76:994-999.
18. Iwai, Y., et al. 2002. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc. Natl. Acad. Sci. U. S. A. 99:12293-12297.
19. Ansari, M.J., et al. 2003. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:63-69.
20. Nishimura, H., and Honjo, T. 2001. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol. 22:265-268.
21. Kurts, C., et al. 1996. Constitutive class 1-restricted exogenous presentation of self antigens in vivo. J. Exp. Med. 184:923-930.
22. Herold, K.C., Montag, A.G., and Buckingham, F. 1992. Induction of tolerance to autoimmune diabetes with islet antigens. J. Exp. Med. 176:1107-1114.
23. Picarella, D.E., Kratz, A., Li, C.B., Ruddle, N.H., and Flavell, R.A. 1993. Transgenic tumor necrosis factor (TNF)-α production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-α and TNF-β transgenic mice. J. Immunol. 150:4136-4150.
24. Guerder, S., Picarella, D.E., Linsley, P.S., and Flavell, R.A. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 91:5138-5142.
25. Cuff, C.A., Sacca, R., and Ruddle, N.H. 1999. Differential induction of adhesion molecule and chemokine expression by LTα3 and LTαβ in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J. Immunol. 162:5965-5972.
26. Luther, S.A., Lopez, T., Bai, W., Hanahan, D., and Cyster, J.G. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 12:471-481.
27. Chen, S.C., et al. 2002. Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J. Immunol. 168:1001-1008.
28. Luther, S.A., et al 2002. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169:424-433.
29. Chatenoud, L., Thervet, E., Primo, J., and Bach, J.F. 1994. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 91:123-127.
30. Tang, Q., et al. 2003. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo. J. Immunol. 170:1510-1516.
31. Carreno, B.M., and Collins, M. 2002. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29-53.
32. Greenwald, R.J., Latchman, Y.E., and Sharpe, A.H. 2002. Negative co-receptors on lymphocytes. Curr. Opin. Immunol. 14 391-396.
33. Balasa, B., et al. 2000. Islet-specific expression of IL-10 promotes diabetes in nonobese diabetic mice independent of Fas, perforin, TNF receptor-1, and TNF receptor-2 molecules J. Immunol. 165:2841-2849.
34. Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., and Honjo, T. 2001. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. U. S. A. 98:13866-13871.
35. Sidorenko, S.P., and Clark, E.A. 2003. The dual-function CD150 receptor subfamily: the viral attraction. Nat. Immunol. 4:19-24.
36. Sharpe, A.H., and Freeman, G.J. 2002. The B7-CD28 superfamily. Nat. Rev. Immunol. 2:116-126.
37. Wang, S., et al. 2003. Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction. J. Exp. Med. 197:1083-1091.
38. Salomon, B., and Bluestone, J.A. 2001. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19:225-252.
39. Blazar, B.R., et al. 2003. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism. J. Immunol. 171:1272-1277.
40. Kanai, T., et al. 2003. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J. Immunol. 171:4156-4163.